Protherics PLC Announces Holding(s) in Company
London, UK; Brentwood, TN, US: 26 February 2008 - Protherics PLC ("Protherics"
or the "Company"), the international biopharmaceutical company focused on
critical care and cancer, announces that, on 25 February 2008, in accordance
with the Transparency Obligations Directive, a notification of interest in the
ordinary share capital of the Company was received from AXA Investment Managers
UK Limited on behalf of AXA S.A. and its Group Companies ("AXA"). Details of
the notification are as follows: